Alveus Therapeutics ApS

Alveus Therapeutics is a clinical-stage biotechnology company focused on developing next-generation therapies for obesity and metabolic diseases. Headquartered in Philadelphia with R&D operations in Copenhagen, the company is backed by a $197 million Series A financing round. Their lead program,...